San Francisco, California 94122


Purpose:

Weight loss is normal for healthy newborns in the first few days, especially for those exclusively breastfed, who may have low enteral intake for several days. Although most newborns tolerate this early period of weight loss well, those with pronounced weight loss become at increased risk of feeding problems and hyperbilirubinemia, which are the two most common causes of neonatal readmission. To facilitate the assessment of risk for an individual newborn, the Newborn Weight Tool (NEWT) has been developed to categorize each infant's weight loss according to population norms, so that formula can be administered when weight loss is pronounced and avoided when weight loss is normal. The Healthy Start study will be a randomized, controlled trial testing whether displaying NEWT to clinicians providing newborn care can improve neonatal health outcomes including formula use, weight loss and readmission. Newborns will be randomly assigned either to display weight with NEWT weight categorization to their providers in the electronic health record (EHR) or to usual care (weight displayed without NEWT categorization).


Criteria:

Inclusion Criteria: - Assignment to a bed assignment on the well newborn service at the time of the first weight measured subsequent to birth weight and at >6 hours and <=96 hours of age Exclusion Criteria:


NCT ID:

NCT03655314


Primary Contact:

Principal Investigator
Valerie Flaherman, MD, MPH
Associate Professor of Pediatrics and Epidemiology and Biostatistics

Michelle Rait, RN
Phone: 415-502-1594
Email: Michelle.Rait@ucsf.edu


Backup Contact:

Email: Kathy.Lanier@ucsf.edu
Kathy Lanier
Phone: 415-514-8136


Location Contact:

San Francisco, California 94122
United States

Valerie Flaherman, MD, MPH
Phone: 415-502-6266
Email: flahermanv@peds.ucsf.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.